| Lot Release Number |
2021-08-10-0395
|
| FDA Registered Product/Generic Name |
TRASTUZUMAB EMTANSINE
|
| Brand Name |
KADCYLA
|
| Dosage Strength |
160 mg
|
| Dosage Form |
POWDER FOR CONCENTRATE FOR SOLUTION FOR I.V. INJECTION
|
| Registration Number |
BR-952
|
| Batch/Lot Number |
B3002
|
| Packaging Lot |
Packaging Lot (Box): B3002B34
|
| Product Expiration Date |
10 November 2023
|
| Issuance Date |
13 August 2021
|